Checkpoint-inhibitor induced Polyserositis with Edema

BACKGROUND: As immune checkpoint inhibitors (ICI) are increasingly being used due to effectiveness in various tumor entities, rare side effects occur more frequently. Pericardial effusion has been reported in patients with advanced non-small cell lung cancer (NSCLC) after or under treatment with imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Zierold, Sarah, Akcetin, Larissa Semra, Gresser, Eva, Maier, Anna Marie, König, Alexander, Kramer, Rafaela, Theurich, Sebastian, Tomsitz, Dirk, Erdmann, Michael, French, Lars E., Rudelius, Martina, Heinzerling, Lucie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588471/
https://www.ncbi.nlm.nih.gov/pubmed/35576074
http://dx.doi.org/10.1007/s00262-022-03211-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588471/
https://www.ncbi.nlm.nih.gov/pubmed/35576074
http://dx.doi.org/10.1007/s00262-022-03211-7

Ejemplares similares